Subscribe to our newsletter for industry insights and research updates.
Loading...
Yellow Fever Virus Vaccine Strain 17D eGFP Reporter
Yellow Fever Virus Vaccine Strain 17D eGFP Reporter is backordered and will ship as soon as it is back in stock.
To support our goal of supplying experiment-ready volumes of virus to our customers, we offer volume-based pricing. Adjusted pricing is applied during checkout.
- Purchase of one vial - list price
- Purchase of two vials - 10% off order
- Purchase of three vials - 20% off order
- Purchase of four or more vials - 30% off order
- For large orders, contact us for a custom quote.
- Academic customers - 60% off order.
Couldn't load pickup availability
Description: Wild-type flavivirus (vaccine strain) expressing the reporter protein eGFP.
Strain History: 17D is the live-attenuated vaccine strain of yellow fever virus (YFV) derived from the virulent human clinical isolate Asibi (Ghana, 1927). Production:Plasmid-based reverse genetics method.
Biosafety Level: 2
Format: 1.0 mL/vial. Clarified and filtered cell culture supernatant frozen at -80°C. Delivered on dry ice.
QA/QC:
Production Batch Information links (downloadable):
Certificate of Analysis
NGS Results and Complete Genome Sequence
Batch Record: Detailed Production and QC Data
Product Use Policy and Material Transfer Agreement
Additional Formats: This product can be made as a purified or inactivated virus stock, or as purified viral genomic material. Many different reporter proteins and molecular tags can be incorporated. Custom variant design and production services are also available. Please contact us for additional information.
Additional Strains: If you require a strain of this virus not listed on our website, please contact us. We can produce a wide range of common strains to meet your needs.
Additional Viruses Available: If you are looking for a virus species or strain not listed on our website, please contact us with your request. Our team will work with you to create the product that meets your research needs and budget.
Strain History: 17D is the live-attenuated vaccine strain of yellow fever virus (YFV) derived from the virulent human clinical isolate Asibi (Ghana, 1927). Production:Plasmid-based reverse genetics method.
Biosafety Level: 2
Format: 1.0 mL/vial. Clarified and filtered cell culture supernatant frozen at -80°C. Delivered on dry ice.
QA/QC:
- Infectious titer
- Genome equivalents/mL by qPCR
- Whole-genome sequencing by NGS
- Mycoplasma test by PCR
- Sterility test for bacterial and fungal contamination
- Endotoxin test <10 EU/mL
- Documented expression of eGFP reporter protein
- Documentation: Experimental conditions for QC tests, documentation of all reagents used.
Production Batch Information links (downloadable):
Certificate of Analysis
NGS Results and Complete Genome Sequence
Batch Record: Detailed Production and QC Data
Product Use Policy and Material Transfer Agreement
Additional Formats: This product can be made as a purified or inactivated virus stock, or as purified viral genomic material. Many different reporter proteins and molecular tags can be incorporated. Custom variant design and production services are also available. Please contact us for additional information.
Additional Strains: If you require a strain of this virus not listed on our website, please contact us. We can produce a wide range of common strains to meet your needs.
Additional Viruses Available: If you are looking for a virus species or strain not listed on our website, please contact us with your request. Our team will work with you to create the product that meets your research needs and budget.